医师认证与人工数据提取在镰状细胞类型识别中高度一致:ASH RC数据枢纽研究
对13个站点9484例患者的医师认证分型显示HbSS占67.2%、HbSC占22.2%等,医师认证分型与人工病历提取的一致率为94%(233/248)。高一致率支持该数据枢纽数据的有效性。
要点
- 医师认证的镰状细胞病分型与人工提取一致率达94%(233/248)。
- 高一致率增强了对真实世界数据用于观察性及干预性研究的信心。
核心结论
- 医师认证的镰状细胞病分型与人工病历提取高度一致,一致率为94%(233/248),支持数据枢纽数据的有效性。
研究设计与样本
- 从13个站点9484例患者中随机抽取每站点25例有医师认证诊断且2022年至少1次就诊的患者进行人工提取。
主要发现
- 患者中位年龄23岁(范围出生至75岁),55.4%为女性。
- 医师认证分型:HbSS 67.2%、HbSC 22.2%、HbSβ0地中海贫血2.1%、HbSβ+地中海贫血6.1%、HbS/其他2.4%。
- 医师认证分型与人工提取的一致率为94%(233/248)。
临床怎么用
- 医师认证可用于镰状细胞病分型的准确识别,支持真实世界数据用于研究和质量改进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sickle cell disease (SCD) is the most common inherited blood disorder in the United States. The American Society of Hematology Research Collaborative (ASH RC) has built an SCD Data Hub (DH) to facilitate research and quality improvement using real-world data. To our knowledge, we report here the first analyses from the DH, focusing on cohort demographics and accurate identification of SCD diagnosis type. DH sites have data use agreements with ASH RC to extract and transfer electronic health record (EHR) data at least quarterly. Principal investigators (PI) provided additional attestation of SCD diagnosis based on existing local data sources deemed sufficient by the PI. A random sample of 25 patients (per site) with a physician-attested diagnosis and at least 1 encounter in 2022 had SCD type and other variables manually abstracted by site personnel. Concordance was calculated as the percentage of cases with the same SCD type determined by the physician-attested and abstracted methods. Twenty DH sites have submitted data for 23 970 unique individuals with SCD. The median patient age was 23 years (range, birth to 75 years); 55.4% were female. Physician-attested SCD diagnosis types on 9484 patients from 13 sites were reported as HbSS (67.2%), HbSC (22.2%), HbSß0thalassemia (2.1%), HbSβ+thalassemia (6.1%), and HbS/other (2.4%). Physician-attested SCD type had 94% (233/248) concordance with manual chart abstraction. High concordance increases confidence in the validity of SCD DH data. Well-curated and transformed data on a large cohort of individuals with SCD will be leveraged to conduct observational studies and inform the design and feasibility of prospective interventional studies.
引用
- Thompson AA, Singh A, Neuberg DS, et al. High concordance of physician-attestation with manual data abstraction for sickle cell type: an ASH RC Data Hub study. Blood Adv. 2026. PMID: 41564435. doi:10.1182/bloodadvances.2025017562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。